NO20004288D0 - FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on - Google Patents

FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on

Info

Publication number
NO20004288D0
NO20004288D0 NO20004288A NO20004288A NO20004288D0 NO 20004288 D0 NO20004288 D0 NO 20004288D0 NO 20004288 A NO20004288 A NO 20004288A NO 20004288 A NO20004288 A NO 20004288A NO 20004288 D0 NO20004288 D0 NO 20004288D0
Authority
NO
Norway
Prior art keywords
aminomethylpyrrolidin
protected
preparation
Prior art date
Application number
NO20004288A
Other languages
English (en)
Other versions
NO20004288L (no
NO317258B1 (no
Inventor
Kwang Yul Moon
Won Sup Kim
Tae Hee Lee
Jay Hyok Chang
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of NO20004288D0 publication Critical patent/NO20004288D0/no
Publication of NO20004288L publication Critical patent/NO20004288L/no
Publication of NO317258B1 publication Critical patent/NO317258B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20004288A 1998-03-04 2000-08-25 Fremgangsmate til fremstilling av et beskyttet 4-aminometyl-pyrrolidin-3-on NO317258B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR19980007079 1998-03-04
KR1019980043636A KR100286874B1 (ko) 1998-03-04 1998-10-19 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
PCT/KR1999/000099 WO1999044991A1 (en) 1998-03-04 1999-03-04 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one

Publications (3)

Publication Number Publication Date
NO20004288D0 true NO20004288D0 (no) 2000-08-25
NO20004288L NO20004288L (no) 2000-10-25
NO317258B1 NO317258B1 (no) 2004-09-27

Family

ID=26633492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004288A NO317258B1 (no) 1998-03-04 2000-08-25 Fremgangsmate til fremstilling av et beskyttet 4-aminometyl-pyrrolidin-3-on

Country Status (29)

Country Link
US (1) US6307059B1 (no)
EP (1) EP1068182B1 (no)
JP (1) JP3374155B2 (no)
KR (1) KR100286874B1 (no)
CN (1) CN1149192C (no)
AP (1) AP1305A (no)
AT (1) ATE297379T1 (no)
AU (1) AU742497B2 (no)
BG (1) BG64674B1 (no)
BR (1) BRPI9908472B8 (no)
CA (1) CA2322540C (no)
CZ (1) CZ301011B6 (no)
DE (1) DE69925721T2 (no)
EA (1) EA002499B1 (no)
ES (1) ES2242382T3 (no)
HU (1) HU228309B1 (no)
ID (1) ID25901A (no)
IL (1) IL137828A0 (no)
IN (1) IN190979B (no)
IS (1) IS2296B (no)
NO (1) NO317258B1 (no)
NZ (2) NZ516778A (no)
OA (1) OA11482A (no)
PT (1) PT1068182E (no)
SK (1) SK285595B6 (no)
TR (3) TR200101800T2 (no)
TW (1) TW453993B (no)
UA (1) UA71907C2 (no)
WO (1) WO1999044991A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
GB9920917D0 (en) * 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
KR20020018560A (ko) * 2000-09-01 2002-03-08 성재갑 3-아미노메틸-4-z-메톡시이미노피롤리딘의 신규 제조방법
ES2314082T3 (es) 2001-08-02 2009-03-16 Lg Life Sciences Limited Procedimientos para la produccion de derivados amino protegidos de 4-aminometilenpirrolidin-3-ona, gemifloxacina y sus sales.
RU2004112787A (ru) * 2001-09-26 2005-10-10 Байер Фармасьютикалс Корпорейшн (US) Производные 1,6-нафтиридина как противодиабетические средства
KR100517638B1 (ko) * 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
KR100515591B1 (ko) * 2003-02-12 2005-09-16 주식회사 엘지화학 4[N-(t-부톡시카르보닐)아미노)메틸렌]-1-N-(t-부톡시카르보닌)피롤리돈-3-온의 제조방법
KR100653334B1 (ko) * 2003-03-07 2006-12-04 주식회사 엘지생명과학 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의 신규한 제조 방법
DE102004010943A1 (de) * 2004-03-03 2005-09-29 Degussa Ag Verfahren zur Herstellung von N-geschützten 4-Ketprolinderivaten
US7185495B2 (en) * 2004-09-07 2007-03-06 General Electric Company System and method for improving thermal efficiency of dry low emissions combustor assemblies
CN104693088B (zh) * 2013-12-06 2018-01-05 常州市勇毅生物药业有限公司 一种吉米沙星侧链的制备方法
CN106349083A (zh) * 2016-08-26 2017-01-25 大连奇凯医药科技有限公司 2,4,6‑三氟苯甲胺的制备方法
KR102233456B1 (ko) * 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
CN113773240B (zh) * 2021-10-12 2022-05-31 北京阳光诺和药物研究股份有限公司 吉米沙星侧链化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309368A (en) * 1965-11-19 1967-03-14 American Cyanamid Co Substituted isoxazoles and methods of preparing the same
US5137892A (en) * 1990-12-12 1992-08-11 Abbott Laboratories Quinoline, naphthyridine and pyridobenzoxazine derivatives
JPH0673056A (ja) * 1992-08-26 1994-03-15 Kaken Pharmaceut Co Ltd キノリンカルボン酸誘導体およびその塩
EP0688772B1 (en) 1994-06-16 1999-05-06 LG Chemical Limited Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation

Also Published As

Publication number Publication date
CA2322540A1 (en) 1999-09-10
CN1149192C (zh) 2004-05-12
EA200000900A1 (ru) 2001-02-26
CZ301011B6 (cs) 2009-10-14
BG64674B1 (bg) 2005-11-30
CN1291975A (zh) 2001-04-18
BR9908472B1 (pt) 2013-11-05
KR19990076521A (ko) 1999-10-15
CA2322540C (en) 2004-11-30
TW453993B (en) 2001-09-11
BR9908472A (pt) 2000-12-05
UA71907C2 (uk) 2005-01-17
IL137828A0 (en) 2001-10-31
JP3374155B2 (ja) 2003-02-04
NZ506312A (en) 2002-04-26
ATE297379T1 (de) 2005-06-15
SK12992000A3 (sk) 2001-11-06
BRPI9908472B8 (pt) 2021-05-25
AP1305A (en) 2004-09-10
DE69925721D1 (de) 2005-07-14
ID25901A (id) 2000-11-09
TR200101801T2 (tr) 2002-06-21
NO20004288L (no) 2000-10-25
NO317258B1 (no) 2004-09-27
HUP0101094A3 (en) 2001-11-28
EA002499B1 (ru) 2002-06-27
PT1068182E (pt) 2005-10-31
US6307059B1 (en) 2001-10-23
AP2000001890A0 (en) 2000-09-30
ES2242382T3 (es) 2005-11-01
JP2002505322A (ja) 2002-02-19
TR200002526T2 (tr) 2001-03-21
IN190979B (no) 2003-09-06
WO1999044991A1 (en) 1999-09-10
AU742497B2 (en) 2002-01-03
SK285595B6 (sk) 2007-04-05
HU228309B1 (en) 2013-03-28
AU2643399A (en) 1999-09-20
IS2296B (is) 2007-10-15
IS5600A (is) 2000-08-22
EP1068182B1 (en) 2005-06-08
CZ20003109A3 (cs) 2001-07-11
HUP0101094A2 (hu) 2001-08-28
OA11482A (en) 2004-05-03
BG104767A (en) 2001-05-31
TR200101800T2 (tr) 2002-04-22
KR100286874B1 (ko) 2001-04-16
NZ516778A (en) 2002-12-20
EP1068182A1 (en) 2001-01-17
DE69925721T2 (de) 2006-03-23

Similar Documents

Publication Publication Date Title
NO980707D0 (no) Fremgangsmåte til fremstilling av kopolymerer
IS2261B (is) Aðferð til framleiðslu á 5-sýanóþalíði
NO20004288L (no) FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO993912L (no) FremgangsmÕte for fremstilling av eprosartan
NO20062796L (no) Fremgangsmate for fremstilling av en dihydroksyaminoforbindelse
NO993913L (no) FremgangsmÕte for fremstilling av eprosartan
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO994131D0 (no) Fremgangsmåte for fremstilling av benzotiazolonforbindelser
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
NO991679L (no) Fremgangsmaate for fremstilling av fenoksyfenylsulfonylhalider
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20005743L (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- glukuronider
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
DK1006799T3 (da) Fremgangsmåde til plantebeskyttelse
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees